青青稞酒(002646.SZ)半年度預盈7000萬-8000萬元 同比扭虧為盈
格隆匯7月13日丨青青稞酒(002646.SZ)公佈,預計2021年半年度歸屬於上市公司股東的淨利潤7000萬元-8000萬元,上年同期虧損3506.64萬元。業績變動原因如下:
1、隨着國內“新冠”疫情的有效控制,國內經濟持續復甦,白酒行業趨勢向好,公司整體業務得到逐步恢復;公司持續聚焦白酒板塊,核心區域業務得到了修復。
2、以利潤為導向,以“大國品牌”IP 的應用為切入點,廣宣內容化,傳播上傾向新媒體。同時,明確了國之德系列、第三代出口型系列、星級系列產品為公司主推產品,調整核心產品價格體系,優化產品結構,百元以上產品佔比以及平均斤單價穩步提升。2021年上半年,整體業績實現扭虧為盈。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.